Direxion Daily S&P Biotech Bear 3x Shares (LABD) News Today $6.79 +0.26 (+3.98%) Closing price 02/21/2025 04:10 PM EasternExtended Trading$6.77 -0.02 (-0.31%) As of 02/21/2025 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisChartDividendHoldingsOwnership All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period Direxion Daily S&P Biotech Bear 3X Shares declares quarterly distribution of $0.1264December 24, 2024 | msn.comDirexion Daily S&P Biotech Bear 3X Shares (LABD) Dividend HistoryDecember 23, 2024 | nasdaq.comDirexion Daily S&P 500 Bear 3X (ARCA:SPXS), Short Interest ReportOctober 15, 2024 | benzinga.comDirexion Daily S&P Biotech Bear 3X Shares declares quarterly distribution of $0.0890September 24, 2024 | msn.comDirexion Daily S&P Biotech Bear 3X ETF (LABD)August 24, 2024 | uk.finance.yahoo.comSPUU Is Still In Negative Drift Mode: August Leveraged ETFs DashboardAugust 2, 2024 | seekingalpha.comSP500: Is It Just A Dip Or The Beginning Of A Bear Market? (Technical Analysis)July 25, 2024 | seekingalpha.comBuy LABU: Biotech Sector Benefits From Lower Interest Rates And AIJuly 22, 2024 | seekingalpha.comDirexion Daily S&P Biotech Bear 3X Shares declares quarterly distribution of $0.0664March 21, 2024 | msn.comSOXS, ARKB and LABD among weekly ETF moversMarch 2, 2024 | msn.comLABD: 3X Leveraged Inverse Fund In Biotechnology Sector Is Best AvoidedJuly 21, 2023 | msn.comDirexion Daily S&P Biotech Bear 3X Shares declares quarterly distribution of $0.0998June 22, 2023 | msn.com5 Factors Why Inverse ETFs May Rule in 2H23June 22, 2023 | msn.comWant Diversified Upside in Biotechnology? Check out LABU (LABD)Watch the Direxion Daily S&P 500 Biotech Bull 3X Shares (NYSEARCA: LABU) if you want a speculative play in the biotechnology industry with amplified volatility.March 22, 2023 | marketbeat.com5 Best Inverse-Leveraged ETFs of FebruaryMarch 1, 2023 | msn.comThis Year's Most Shorted ETFsFebruary 24, 2023 | finance.yahoo.com5 Least-Hurt Biotech ETFs of the Last WeekFebruary 15, 2023 | finance.yahoo.comLABU Direxion Daily S&P Biotech Bull 3x Shares ETFJanuary 29, 2023 | seekingalpha.comThe Sell Rating Of LABD Is ReaffirmedNovember 3, 2022 | seekingalpha.comLABD: A Bad Bad DriftNovember 2, 2022 | seekingalpha.comBiotech Bounces in August as M&A Activity IncreasesSeptember 2, 2022 | finance.yahoo.comDirexion Daily S&P Biotech Bear 3X ETF LABDJune 7, 2022 | morningstar.comLABD Direxion Daily S&P Biotech Bear 3x Shares ETFApril 30, 2022 | seekingalpha.comBiotech Belonged to the Bears in Second Half of 2021January 1, 2022 | finance.yahoo.comIO Biotech Shares Halted On Circuit Breaker To Upside; Up 49%December 5, 2021 | benzinga.comWhy Affirm Shares Are FallingDecember 5, 2021 | benzinga.comDirexion Daily S&P Biotech Bear 3X Shares(LABD)November 5, 2021 | fool.comThis Bearish Biotech ETF Is up 16% in the Past MonthOctober 12, 2021 | nasdaq.comWorst Performing ETFs of 2020September 9, 2021 | investopedia.com Get Direxion Daily S&P Biotech Bear 3x Shares News Delivered to You Automatically Sign up to receive the latest news and ratings for LABD and its competitors with MarketBeat's FREE daily newsletter. Email Address LABD Media Mentions By Week LABD Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LABD News Sentiment▼0.000.70▲Average News Sentiment LABD News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LABD Articles This Week▼00▲LABD Articles Average Week Get Direxion Daily S&P Biotech Bear 3x Shares News Delivered to You Automatically Sign up to receive the latest news and ratings for LABD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies BIB News IBBQ News XHS News MEDI News BIS News PINK News XPH News PSCH News PPH News IHE News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSEARCA:LABD) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | Sponsored[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Direxion Daily S&P Biotech Bear 3x Shares Please log in to your account or sign up in order to add this asset to your watchlist. Share Direxion Daily S&P Biotech Bear 3x Shares With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.